BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31059154)

  • 1. Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy.
    Chen Z; Chen JA; Shatunov A; Jones AR; Kravitz SN; Huang AY; Lawrence L; Lowe JK; Lewis CM; Payan CAM; Lieb W; Franke A; Deloukas P; Amouyel P; Tzourio C; Dartigues JF; ; Ludolph A; Bensimon G; Leigh PN; Bronstein JM; Coppola G; Geschwind DH; Al-Chalabi A
    Mov Disord; 2019 Jul; 34(7):1049-1059. PubMed ID: 31059154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.
    Allen M; Burgess JD; Ballard T; Serie D; Wang X; Younkin CS; Sun Z; Kouri N; Baheti S; Wang C; Carrasquillo MM; Nguyen T; Lincoln S; Malphrus K; Murray M; Golde TE; Price ND; Younkin SG; Schellenberg GD; Asmann Y; Ordog T; Crook J; Dickson D; Ertekin-Taner N
    Acta Neuropathol; 2016 Aug; 132(2):197-211. PubMed ID: 27115769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.
    Kouri N; Ross OA; Dombroski B; Younkin CS; Serie DJ; Soto-Ortolaza A; Baker M; Finch NCA; Yoon H; Kim J; Fujioka S; McLean CA; Ghetti B; Spina S; Cantwell LB; Farlow MR; Grafman J; Huey ED; Ryung Han M; Beecher S; Geller ET; Kretzschmar HA; Roeber S; Gearing M; Juncos JL; Vonsattel JPG; Van Deerlin VM; Grossman M; Hurtig HI; Gross RG; Arnold SE; Trojanowski JQ; Lee VM; Wenning GK; White CL; Höglinger GU; Müller U; Devlin B; Golbe LI; Crook J; Parisi JE; Boeve BF; Josephs KA; Wszolek ZK; Uitti RJ; Graff-Radford NR; Litvan I; Younkin SG; Wang LS; Ertekin-Taner N; Rademakers R; Hakonarsen H; Schellenberg GD; Dickson DW
    Nat Commun; 2015 Jun; 6():7247. PubMed ID: 26077951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
    Höglinger GU; Melhem NM; Dickson DW; Sleiman PM; Wang LS; Klei L; Rademakers R; de Silva R; Litvan I; Riley DE; van Swieten JC; Heutink P; Wszolek ZK; Uitti RJ; Vandrovcova J; Hurtig HI; Gross RG; Maetzler W; Goldwurm S; Tolosa E; Borroni B; Pastor P; ; Cantwell LB; Han MR; Dillman A; van der Brug MP; Gibbs JR; Cookson MR; Hernandez DG; Singleton AB; Farrer MJ; Yu CE; Golbe LI; Revesz T; Hardy J; Lees AJ; Devlin B; Hakonarson H; Müller U; Schellenberg GD
    Nat Genet; 2011 Jun; 43(7):699-705. PubMed ID: 21685912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent trait modeling of tau neuropathology in progressive supranuclear palsy.
    Kouri N; Murray ME; Reddy JS; Serie DJ; Soto-Beasley A; Allen M; Carrasquillo MM; Wang X; Castanedes MC; Baker MC; Rademakers R; Uitti RJ; Graff-Radford NR; Wszolek ZK; Schellenberg GD; Crook JE; Ertekin-Taner N; Ross OA; Dickson DW
    Acta Neuropathol; 2021 May; 141(5):667-680. PubMed ID: 33635380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.
    Ezquerra M; Pastor P; Gaig C; Vidal-Taboada JM; Cruchaga C; Muñoz E; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
    Neurobiol Aging; 2011 Mar; 32(3):547.e11-6. PubMed ID: 19879020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.
    Pittman AM; Myers AJ; Abou-Sleiman P; Fung HC; Kaleem M; Marlowe L; Duckworth J; Leung D; Williams D; Kilford L; Thomas N; Morris CM; Dickson D; Wood NW; Hardy J; Lees AJ; de Silva R
    J Med Genet; 2005 Nov; 42(11):837-46. PubMed ID: 15792962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy.
    Ferrari R; Ryten M; Simone R; Trabzuni D; Nicolaou N; Hondhamuni G; Ramasamy A; Vandrovcova J; ; Weale ME; Lees AJ; Momeni P; Hardy J; de Silva R
    Neurobiol Aging; 2014 Jun; 35(6):1514.e1-12. PubMed ID: 24503276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.
    Borroni B; Agosti C; Magnani E; Di Luca M; Padovani A
    Curr Med Chem; 2011; 18(17):2655-60. PubMed ID: 21568901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci.
    Sanchez-Contreras MY; Kouri N; Cook CN; Serie DJ; Heckman MG; Finch NA; Caselli RJ; Uitti RJ; Wszolek ZK; Graff-Radford N; Petrucelli L; Wang LS; Schellenberg GD; Dickson DW; Rademakers R; Ross OA
    Mol Neurodegener; 2018 Jul; 13(1):37. PubMed ID: 29986742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
    Heckman MG; Brennan RR; Labbé C; Soto AI; Koga S; DeTure MA; Murray ME; Petersen RC; Boeve BF; van Gerpen JA; Uitti RJ; Wszolek ZK; Rademakers R; Dickson DW; Ross OA
    JAMA Neurol; 2019 Jun; 76(6):710-717. PubMed ID: 30882841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of progressive supranuclear palsy in a Chinese population.
    Xiao X; Yang Q; Wen Y; Jiao B; Liao X; Zhou Y; Weng L; Liu H; Xu T; Zhu Y; Guo L; Zhou L; Wang X; Liu X; Bi X; Liu Y; Zhang S; Zhang W; Li J; Tang B; Shen L
    Neurobiol Dis; 2022 Oct; 172():105819. PubMed ID: 35842134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of Progressive Supranuclear Palsy: A Review.
    Wen Y; Zhou Y; Jiao B; Shen L
    J Parkinsons Dis; 2021; 11(1):93-105. PubMed ID: 33104043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study.
    Jabbari E; Koga S; Valentino RR; Reynolds RH; Ferrari R; Tan MMX; Rowe JB; Dalgard CL; Scholz SW; Dickson DW; Warner TT; Revesz T; Höglinger GU; Ross OA; Ryten M; Hardy J; Shoai M; Morris HR;
    Lancet Neurol; 2021 Feb; 20(2):107-116. PubMed ID: 33341150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the tau gene region chromosome inversion in progressive supranuclear palsy, corticobasal degeneration, and related disorders.
    Webb A; Miller B; Bonasera S; Boxer A; Karydas A; Wilhelmsen KC
    Arch Neurol; 2008 Nov; 65(11):1473-8. PubMed ID: 19001166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.
    Chen JA; Chen Z; Won H; Huang AY; Lowe JK; Wojta K; Yokoyama JS; Bensimon G; Leigh PN; Payan C; Shatunov A; Jones AR; Lewis CM; Deloukas P; Amouyel P; Tzourio C; Dartigues JF; Ludolph A; Boxer AL; Bronstein JM; Al-Chalabi A; Geschwind DH; Coppola G
    Mol Neurodegener; 2018 Aug; 13(1):41. PubMed ID: 30089514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy.
    Rademakers R; Melquist S; Cruts M; Theuns J; Del-Favero J; Poorkaj P; Baker M; Sleegers K; Crook R; De Pooter T; Bel Kacem S; Adamson J; Van den Bossche D; Van den Broeck M; Gass J; Corsmit E; De Rijk P; Thomas N; Engelborghs S; Heckman M; Litvan I; Crook J; De Deyn PP; Dickson D; Schellenberg GD; Van Broeckhoven C; Hutton ML
    Hum Mol Genet; 2005 Nov; 14(21):3281-92. PubMed ID: 16195395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of the tau haplotype in controls and in progressive supranuclear palsy.
    Pittman AM; Myers AJ; Duckworth J; Bryden L; Hanson M; Abou-Sleiman P; Wood NW; Hardy J; Lees A; de Silva R
    Hum Mol Genet; 2004 Jun; 13(12):1267-74. PubMed ID: 15115761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation at the tau locus and clinical syndromes associated with progressive supranuclear palsy.
    Williams DR; Pittman AM; Revesz T; Lees AJ; de Silva R
    Mov Disord; 2007 Apr; 22(6):895-7. PubMed ID: 17274033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel L284R MAPT mutation in a family with an autosomal dominant progressive supranuclear palsy syndrome.
    Rohrer JD; Paviour D; Vandrovcova J; Hodges J; de Silva R; Rossor MN
    Neurodegener Dis; 2011; 8(3):149-52. PubMed ID: 20838030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.